Skip to main content

Latest SEC Filings — Page 180

Page 180 · 30 filings scored 7+ · newest 4:05 PM ET · How scores work

Thu, Aug 1330 filings
8SGLASino Green Land Corp.SGLA to Acquire Two Malaysian Plastics Companies for 26.7 Million SharesForm 8-K · Current report● NeutralPro7NNENano Nuclear Energy Inc.Nano Nuclear Reports $580M Cash Position and NRC Review Timeline for KRONOSForm 8-K · Current report▲ Positive7BLNEBeeline Holdings, Inc.Beeline Q2 Revenue Jumps 57% as CEO Invests $500K Above MarketForm 8-K · Current report▲ Positive8BOFBranchOut Food Inc.BranchOut Food Guides to Record Q4 Revenue of $6-7M on Doubling ProductionForm 8-K · Current report▲ PositivePro7MDBHMDB Capital Holdings, LLCMDB Capital Posts Wider Q2 Loss as eXoZymes Stake DeterioratesForm 10-Q · Periodic report▼ Negative7KYNBKyntra Bio, Inc.Kyntra Bio Q2: $95.7M Cash, Roxadustat Phase 3 Start Set for 4QForm 8-K · Current report▲ Positive7ZSPCzSpace, Inc.zSpace Swings to Q2 Profit on Margin Surge, But Cash Dwindles to $0.9MForm 8-K · Current report● Neutral7STNEStoneCo Ltd.StoneCo Q2 Earnings: Net Income Misses Estimates, Credit Quality DeterioratesForm 6-K · Current report▼ Negative8MDXHMDxHealth SAMDxHealth Raises $20M in Registered Direct Offering at $0.454/ShareForm 6-K · Current report▼ NegativePro8HAWKHawkEye 360, Inc.HawkEye 360 Q2 Revenue Up 87% to $49.8M, Guides FY26 Revenue $215-220MForm 8-K · Current report▲ PositivePro7NNOXNano-X Imaging Ltd.Nano-X Seeks Shareholder Approval to Add 50M Authorized Shares at Sept 17 AGMForm 6-K · Current report▼ Negative7STNEStoneCo Ltd.StoneCo Q2 Net Income Misses Estimates; One-Time Tax Benefit Masks Underlying WeaknessForm 6-K · Current report▼ Negative8VTSIVirTra, IncVirTra Q2 Revenue Falls 17%, Material Weaknesses PersistForm 10-Q · Periodic report▼ NegativePro7INBXInhibrx Biosciences, Inc.Inhibrx Q2 Loss Widens to $36.7M; Cash at $133.3M Before $100M July DrawForm 10-Q · Periodic report▼ Negative7THRMGentherm IncGentherm Mails Definitive Proxy for Modine Merger; Shareholder Vote Set for September 10Form 425 · Proxy● Neutral8RVRCRevium Rx.Revium Rx. Reiterates Going Concern, Reports $1.5M Cash and Ineffective ControlsForm 10-Q · Periodic report▼ NegativePro8AMATApplied Materials, Inc.Applied Materials Posts Record Q3 Revenue of $9.12B, Raises Q4 Guidance to $10.25BForm 8-K · Current report▲ PositivePro7FENCFennec Pharmaceuticals Inc.Fennec Q2 Sales Jump 78% to $17.1M, Swings to ProfitForm 10-Q · Periodic report▲ Positive7CODXCo-Diagnostics, Inc.Co-Diagnostics Advances Flu/RSV Test Toward FDA Clearance and Names New CSOForm 8-K · Current report● Neutral8SPRYARS Pharmaceuticals, Inc.ARS Pharma Slashes 2H Spend by 40%, Aims for Cash Flow Breakeven by End of 2027Form 8-K · Current report● NeutralPro8GETYGetty Images Holdings, Inc.Getty Images Pursues Reverse Split to Avert NYSE DelistingPRE 14A · Proxy▼ NegativePro8NXXTNEXTNRG, INC.NextNRG Q2 Loss Narrows 82% but Going Concern Warning PersistsForm 10-Q · Periodic report▼ NegativePro8SLXNSilexion Therapeutics CorpSilexion Closes $2.5M Public Offering with Warrants and Converts Sponsor NoteForm 8-K · Current report▼ NegativePro7TMCTMC the metals Co Inc.TMC Posts Q2 Loss and Halts Capital Raises Pending U.S. FundingForm 8-K · Current report● Neutral7SMSISmith Micro Software, Inc.Smith Micro Q2 Revenue Grows Sequentially, Loss Narrows; Two New Customers Ready to LaunchForm 8-K · Current report▲ Positive7HTFLHeartflow, Inc.Heartflow Q2 Revenue Jumps 48%, Raises Full-Year GuidanceForm 8-K · Current report▲ Positive8BEATHeartBeam, Inc.HeartBeam Q2 2026: $5.0M Net Loss, Going Concern Warning, and $11.5M RaiseForm 10-Q · Periodic report▼ NegativePro7AKTXAkari Therapeutics PlcAkari Therapeutics Q2 2026: Wider Loss, $7.7M Cash, Phase 1 Trial Set for Mid-2027Form 8-K · Current report● Neutral8DAREDare Bioscience, Inc.Dare Bioscience Launches First Commercial Product, Reports Q2 Results and Positive Ovaprene DataForm 8-K · Current report▲ PositivePro8GOSSGossamer Bio, Inc.Debt Extinguishment Drives Q2 Profit for Gossamer Bio; NDA Submission on Track for SeptemberForm 8-K · Current report▲ PositivePro
How Wiseek picks and scores these

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.